Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Withdrawn Phase 2 Interventional

Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney Disease

ClinicalTrials.gov ID: NCT06598631

Public ClinicalTrials.gov record NCT06598631. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 6:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to investigate the efficacy and safety of Volenrelaxin in adults with Chronic Kidney Disease. The study will last about 24 weeks.

Study identification

NCT ID
NCT06598631
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2024 (Estimated)
Primary completion
Dec 2024 (Estimated)
Completion
Dec 2024 (Estimated)
Last update posted
Sep 8, 2026

2024

United States locations

U.S. sites
16
U.S. states
7
U.S. cities
16
Facility City State ZIP Site status
Rancho Research Institute Downey California 90242 —
Southwest Nephrology Associates Evergreen Park Illinois 60805 —
Nephrology Associates of Northern Illinois and Indiana (NANI) - Hinsdale Hinsdale Illinois 60521 —
Nephrology Associates of Northern Illinois and Indiana (NANI) - Huntley Huntley Illinois 60142 —
Nephrology Associates of Northern Illinois and Indiana (NANI) - Fort Wayne Fort Wayne Indiana 46804 —
Nephrology Associates of Northern Illinois and Indiana - IKS - Indianapolis South Indianapolis Indiana 46227 —
Diabetes and Metabolism Associates, APMC Metairie Louisiana 70006 —
Elite Clinical Research Center Flint Michigan 48532 —
Eastern Nephrology Associates - Greenville Greenville North Carolina 27834 —
Eastern Nephrology Associates Jacksonville North Carolina 28546 —
Eastern Nephrology Associates- Kinston Office Kinston North Carolina 28504 —
Lucas Research, Inc. Morehead City North Carolina 28557 —
Eastern Nephrology Associates- New Bern Office New Bern North Carolina 28562 —
Eastern Nephrology Associates - Wilmington Wilmington North Carolina 28401 —
Endocrine Associates Houston Texas 77004 —
Permian Research Foundation Odessa Texas 79761 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06598631, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 8, 2026 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06598631 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →